Schulman Amy W

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
15 Oct 24	CAMP4 Therapeutics	Common Stock	Buy	Acquire P	Yes	No	11	909,090	10.00 mm	909,090
15 Oct 24	CAMP4 Therapeutics	Common Stock	Conversion	Acquire C	Yes	No	0	24,745	0.00	112,193
15 Oct 24	CAMP4 Therapeutics	Common Stock	Conversion	Acquire C	Yes	No	0	353,718	0.00	1,603,779
15 Oct 24	CAMP4 Therapeutics	Common Stock	Conversion	Acquire C	Yes	No	0	87,448	0.00	87,448
15 Oct 24	CAMP4 Therapeutics	Common Stock	Conversion	Acquire C	Yes	No	0	1,250,061	0.00	1,250,061
15 Oct 24	CAMP4 Therapeutics	Series B Preferred Stock Common Stock	Conversion	Dispose C	Yes	No	0	277,536	0.00	0
15 Oct 24	CAMP4 Therapeutics	Series B Preferred Stock Common Stock	Conversion	Dispose C	Yes	No	0	3,967,234	0.00	0
15 Oct 24	CAMP4 Therapeutics	Series A Prime Preferred Stock Common Stock	Conversion	Dispose C	Yes	No	0	980,829	0.00	0
15 Oct 24	CAMP4 Therapeutics	Series A Prime Preferred Stock Common Stock	Conversion	Dispose C	Yes	No	0	14,020,475	0.00	0
25 Jun 24	ALNY Alnylam Pharmaceuticals	Common Stock	Sell	Dispose S	No	Yes	240	8,500	2.04 mm	8,436

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.